CN1042597C - Vision-brighting and blood sugar decreasing composition and its produciton - Google Patents
Vision-brighting and blood sugar decreasing composition and its produciton Download PDFInfo
- Publication number
- CN1042597C CN1042597C CN91108966A CN91108966A CN1042597C CN 1042597 C CN1042597 C CN 1042597C CN 91108966 A CN91108966 A CN 91108966A CN 91108966 A CN91108966 A CN 91108966A CN 1042597 C CN1042597 C CN 1042597C
- Authority
- CN
- China
- Prior art keywords
- radix
- extractum
- manufacture method
- compound
- reducing blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention relates to a composition which has an obvious therapeutic effect on diabetes, particularly to on diabetes concurrent with ocular diseases, and a preparation method thereof. The composition adopts proper Chinese herbal medicines as main raw materials and is prepared with the technology of decoction, extract making, shaping, etc. The composition has the advantages of obvious effect, convenient administration, etc. and is suitable for various diabetic patients, especially for patients with diabetes concurrent with ocular diseases.
Description
The present invention relates to a kind ofly, particularly diabetes complicated ocular disease is had the manufacture method of the compositions of significant curative effect diabetes.
Diabetes are a kind of chronic progressive diseases, and especially diabetes complicated with ophthalmopathy becomes, and cause losing one's sight, and cause great misery for especially patient and family members thereof.And some medicines that use in the present hospital, some Western medicine has side effect.For example: new drug " glyburide ", drug effect is fast and strong, but can cause hypoglycemia, blurred vision, side effect such as trembling of limbs.And for example: " insulin " injection is a specific medicament, but only can substitute additional hyposecretion, can not the disease controlling development, and some oral Chinese herbal medicine effect is not fairly obvious, and decocts medicinal herbs time-consuming bothersomely, and the patient often can not adhere to taking medicine for a long time.
The purpose of this invention is to provide a kind ofly, especially diabetes complicated ocular disease is had the manufacture method of the compositions of special significant curative effect and taking convenience for various diabetes.
To achieve the above object of the invention, the present invention adopts following embodiment: a kind of manufacture method of the compound for reducing blood suger that makes eye bright is characterized in that: it comprises following material medicine:
Concha Haliotidis 5-100g Semen Cassiae 5-100g
Calculus Bovis 3-30g Rhizoma Coptidis 3-50g
Fel Ursi 3-50g Herba Dendrobii 3-100g
Ootheca Mantidis 5-100g Semen Celosiae 3-100g
Fructus Schisandrae Chinensis 5-100g SHANZHIZI 5-100g
Radix Ophiopogonis 5-100g Radix Rehmanniae 10-200g
Radix Angelicae Sinensis 5-100g Flos Carthami 3-50g
Radix Trichosanthis 50-100g Fructus Corni 5-100g
Field dobber 5-100g Radix Bupleuri 3-100g
Radix Adenophorae (Radix Glehniae) 5-100g Korean Ginseng 5-100g
Fructus Lycii 3-100g Radix Asparagi 5-100g
Calculus Bovis in the described material medicine, Rhizoma Coptidis, Fel Ursi, Korean Ginseng pulverize is standby, described all the other material medicines are put into pot, add 1-6 water doubly; decoct secondary 60-90 minute with fire, the elimination bits are condensed into extractum with surplus liquid; pour described standby powder into, stir, then typing.
Describedly after secondary decocts the elimination bits, decoct, surplus liquid can be condensed into extractum with low baking temperature.
Described after secondary decocts the elimination bits, also surplus liquid can be placed air, natural evaporation becomes extractum.
Described standby powder and extractum that described typing will stir incapsulate.
Described standby powder and extractum that described typing also will stir are poured comminutor into and are made tablet or sublimed preparation.
The present invention makes the beneficial effect highly significant of ingredient owing to select suitable material medicine to adopt suitable manufacture method.Played the effect of liver heat removing and eyesight improving as Concha Haliotidis, Semen Cassiae, Calculus Bovis, Rhizoma Coptidis, Fel Ursi, Semen Celosiae, cure mainly have a dizzy spell, disease such as blurring of vision; Fructus Lycii, Radix Asparagi, Radix Ophiopogonis, the Radix Rehmanniae, Radix Trichosanthis, Fructus Corni have played the effect of enriching yin and nourishing kidney, cure mainly soreness of the waist and knees, and urine is anxious frequently; Radix Adenophorae (Radix Glehniae), Ootheca Mantidis, field dobber, Korean Ginseng have played the effect that yin nourishing is quenched the thirst, and cure mainly the weak disease of waiting all over the body.Adopt the compositions of the inventive method manufacturing can be widely used in the various diabetes of treatment, have no side effect and taking convenience.
Describing the present invention below in conjunction with embodiment, is explanation the preferred embodiments of the present invention in an embodiment, is not in order to restriction the present invention.
Embodiment 1, the present invention select following material medicine standby
Concha Haliotidis 100g Semen Cassiae 100g
Calculus Bovis 30g Rhizoma Coptidis 50g
Fel Ursi 20g Herba Dendrobii 100g
Ootheca Mantidis 100g Semen Celosiae 100g
Fructus Schisandrae Chinensis 100g SHANZHIZI 100g
Radix Ophiopogonis 100g Radix Rehmanniae 200g
Radix Angelicae Sinensis 100g Flos Carthami 50g
Radix Trichosanthis 100g Fructus Corni 100g
Field dobber 100g Radix Bupleuri 100g
Radix Adenophorae (Radix Glehniae) 100g Korean Ginseng 100g
Chinese holly reading notes 100g Radix Asparagi 100g
With the Calculus Bovis in the above-mentioned raw materials medicine, Rhizoma Coptidis, Fel Ursi, Korean Ginseng, standby with the herb roller pulverize; Above-mentioned all the other material medicines are put into the water that the medicine pot adds 4 times, fried in shallow oil secondary 60 minutes with moderate heat, the elimination bits are condensed into extractum with surplus liquid with low baking temperature.Described standby powder is added in the extractum, stir.This moment, compositions was granule or Powdered, and granule or powdered composition are incapsulated.
Embodiment 2, the present invention select following material medicine standby
Concha Haliotidis 20g Semen Cassiae 10g
Calculus Bovis 3g Rhizoma Coptidis 5g
Fel Ursi 3g Herba Dendrobii 10g
Ootheca Mantidis 10g Semen Celosiae 10g
Fructus Schisandrae Chinensis 15g SHANZHIZI 5g
Radix Ophiopogonis 20g Radix Rehmanniae 30g
Radix Angelicae Sinensis 10g Flos Carthami 10g
Radix Trichosanthis 15g Fructus Corni 5g
Field dobber 10g Radix Bupleuri 10g
Radix Adenophorae (Radix Glehniae) 10g Korean Ginseng 10g
Fructus Lycii 15g Radix Asparagi 15g
With the Calculus Bovis in the above-mentioned raw materials medicine, Rhizoma Coptidis, Fel Ursi, Korean Ginseng, standby with the herb roller pulverize, above-mentioned all the other material medicines are put into the medicine pot add 2 times of water; fried in shallow oil secondary 90 minutes with moderate heat, the elimination bits place air with surplus liquid; make its natural evaporation, until becoming extractum.Described standby powder is added in the extractum, stir, will go into capsule.
In above-mentioned two embodiment, standby powder is added after extractum stirs, also can pour comminutor into, be made into tablet or sublimed preparation.
Use the present composition 289 routine clinical effectiveness as follows:
The shared % of curative effect example number
Clinical cure 58 examples 20%
Produce effects 112 examples 38.7%
Effective 79 examples 27.3%
Invalid 40 examples 14%
This medicine observation period is 60-180 days
Exemplify three cases below:
Case 1
Open * * woman suffers from diabetes in May, 34 1985, polydipsia, polyuria, polyphagia, becomes thin, and body weight drops to 35 kilograms by 53 kilograms, answer insulinize, 40 unit/days of consumption per day, blood glucose 250mg/dl, glucose in urine +++, vision has obviously and goes down left eye 0.2, right eye 0.3 increases and takes the present composition after 130 days, and insulin reduced to for 20 unit/days, blood glucose drops to 130mg/dl, glucose in urine ++, vision restoration is 1.0, and is good so far.
Case 2
Zhao * * diabetes suffered from 10 years in women 51 years old, long-term oral glyburide, D860, insoral, Drug therapys such as diamicron, do not feel any better, vision obviously descends, left eye 0.3, right eye 0.1, blurring of vision, in November, 1988, the oral administration present composition was 95 days, transference cure, vision restoration to 0.9.
Case 3
Wu * * man suffered from diabetes in 58 years old 4 years, and the polydipsia polyphagia, is become thin at polyuria, blood glucose 280mg/dl, glucose in urine +++, visual deterioration, left eye 0.4, right eye 0.3, and retinal hemorrhage is arranged.Began to take the present composition 115 days in November, 1988, blood glucose 118mg/dl, and glucose in urine ++, vision restoration to 1.0 is good so far.
Claims (5)
1, a kind of manufacture method of the compound for reducing blood suger that makes eye bright is characterized in that: it comprises following material medicine:
Concha Haliotidis 5-100g Semen Cassiae 5-100g
Calculus Bovis 3-30g Rhizoma Coptidis 3-50g
Fel Ursi 3-50g Herba Dendrobii 3-100g
Ootheca Mantidis 5-100g Semen Celosiae 3-100g
Fructus Schisandrae Chinensis 5-100g SHANZHIZI 5-100g
Radix Ophiopogonis 5-100g Radix Rehmanniae 10-200g
Radix Angelicae Sinensis 5-100g Flos Carthami 3-50g
Radix Trichosanthis 50-100g Fructus Corni 5-100g
Field dobber 5-100g Radix Bupleuri 3-100g
Radix Adenophorae (Radix Glehniae) 5-100g Korean Ginseng 5-100g
Fructus Lycii 3-100g Radix Asparagi 5-100g
Calculus Bovis in the described material medicine, Rhizoma Coptidis, Fel Ursi, Korean Ginseng pulverize is standby, described all the other material medicines are put into pot, add 1-6 water doubly; decoct secondary 60-90 minute with fire, the elimination bits are condensed into extractum with surplus liquid; pour described standby powder into, stir, then typing.
2, the manufacture method of a kind of compound for reducing blood suger that makes eye bright according to claim 1 is characterized in that: describedly decoct with low baking temperature after secondary decocts the elimination bits, surplus liquid is condensed into extractum.
3, the manufacture method of a kind of compound for reducing blood suger that makes eye bright according to claim 1 is characterized in that: described after secondary decocts the elimination bits, surplus liquid is placed air, and natural evaporation becomes extractum.
4, the manufacture method of a kind of compound for reducing blood suger that makes eye bright according to claim 1 is characterized in that: described typing is that described standby powder and the extractum that will stir incapsulate.
5, the manufacture method of a kind of compound for reducing blood suger that makes eye bright according to claim 1 is characterized in that: described typing is described standby powder and the extractum that will stir, and pours comminutor into and makes tablet or sublimed preparation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN91108966A CN1042597C (en) | 1991-09-21 | 1991-09-21 | Vision-brighting and blood sugar decreasing composition and its produciton |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN91108966A CN1042597C (en) | 1991-09-21 | 1991-09-21 | Vision-brighting and blood sugar decreasing composition and its produciton |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1071079A CN1071079A (en) | 1993-04-21 |
| CN1042597C true CN1042597C (en) | 1999-03-24 |
Family
ID=4909567
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN91108966A Expired - Fee Related CN1042597C (en) | 1991-09-21 | 1991-09-21 | Vision-brighting and blood sugar decreasing composition and its produciton |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1042597C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1051010C (en) * | 1995-06-02 | 2000-04-05 | 苗毅韧 | Quick-acting Chinese medicine "Jiangtang Fumingwan" pill for curing diabetes and complication and its preparation technology |
| KR100195886B1 (en) * | 1996-11-01 | 1999-06-15 | 김상조 | Pharmaceutical composition for treating diabetes mellitus |
| CN102552533B (en) * | 2012-02-15 | 2014-05-07 | 梁艳龙 | Chinese medicinal formula for treating diabetes |
-
1991
- 1991-09-21 CN CN91108966A patent/CN1042597C/en not_active Expired - Fee Related
Non-Patent Citations (4)
| Title |
|---|
| 河南中医1983(6) 1983.6.30 糖尿病合并眼底出血的治疗 * |
| 河南中医1983(6) 1983.6.30 糖尿病合并眼底出血的治疗;湖南中医杂志19895(3) 1989.3.15 三消汤治疗糖尿病;辽宁中医杂志1982(9) 1983.9.30 润燥活血汤的应用 * |
| 湖南中医杂志19895(3) 1989.3.15 三消汤治疗糖尿病 * |
| 辽宁中医杂志1982(9) 1983.9.30 润燥活血汤的应用 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1071079A (en) | 1993-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1079027C (en) | Pharmaceutical composition for diabetes | |
| CN1742939A (en) | Medicine for treating pulmonary fibrosis and preparing method | |
| CN104623201B (en) | A kind of liver protection Elmination of toxicant and fat-lowering hypoglycemic medicine and its application | |
| CN1857690A (en) | Gynecopathy treating preparation and its preparing process | |
| CN1814167A (en) | Health-care for diabetes | |
| CN1051237C (en) | Meicinal prepn. "Kexianling" for curing epilepsy | |
| CN101053621A (en) | Traditional Chinese medicinal composition for treating obesity and its preparation method | |
| CN1762458A (en) | Hyperlipemia treating medicine and its preparation method | |
| CN1042597C (en) | Vision-brighting and blood sugar decreasing composition and its produciton | |
| CN1052889C (en) | Chinese proprietary for curing hepatitis | |
| CN1107711A (en) | Hypoglycemic compound capsule | |
| CN1562116A (en) | Chinese medicine preparation with invigorating kidney function | |
| CN1319586C (en) | Medicinal composition for treating brain apoplexy | |
| CN1876148A (en) | A Chinese medicinal composition for replenishing kidney and strengthening bone and preparation method thereof | |
| CN1544047A (en) | Chinese traditional medicine composition for treating cancer and its preparation | |
| CN1333044A (en) | Wasting-thirst hypoglycemic preparation | |
| CN1097333A (en) | A kind of pure plant health preparation glycolipid disappears and method for making | |
| CN1666763A (en) | Dripping pills of six Ingredients with Rehmanniae | |
| CN1686365A (en) | Medicinal composition for treating diabetes and its preparation method | |
| CN1279961C (en) | Chinese prepared drug formulation for stopping cough and eliminating sputum and its preparation process | |
| CN101062348A (en) | Ganoerma lucidum capusule for reducing blood sugar | |
| CN1062745C (en) | Shuangshi Zaishengjing oral liquor and preparation method thereof | |
| CN1194722C (en) | Shugan Zhitong soft extract for treating hepatitis | |
| CN1122524C (en) | Chinese medicine for treating diabetes and its preparing process | |
| CN1456227A (en) | Medicine for curing hepatitis B |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C15 | Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993) | ||
| OR01 | Other related matters | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |